Non-invasive imaging has revolutionised the diagnosis of the most common cardiovascular diseases. At Animascope, state-of-the-art technologies are used to support the development of new methods of diagnostics, prognostic, and therapeutic efficacy evaluation for newly developed treatments.
We offer preclinical imaging services in an ethical and technical environment which allow our specialized
teams to exploit a dedicated small animal imaging platform and to produce reproducible and reliable results for small studies as well as large cohorts being studied longitudinally.
Nuclear imaging is used to detect in a noninvasive way the in vivo
distribution of a radiolabelled compound, named radiotracer or
radiopharmaceutical. A lot of various radiopharmaceuticals are
available. Thus, nuclear imaging allows gathering quantitative
information about the functions of a particular tissue or organs
by analysing acquired whole body 3D or planar images
(scintigraphy). Depending on the isotope used to label a molecule
of interest, two types of technologies are used in clinical centers:
Single photon emission computed tomography (SPECT) and positron
emission tomography (PET). Both are widely used for common
examination in nuclear medicine departments. For example,
glucose labeled with fluorine 18 (FDG) is used to assess glucose
metabolism which is increased in tumor cells.
To see the complete technical file for cardioimaging, please click here.